Sanofi-Aventis U.S. LLC is recalling approximately 11,474 cartons of Enoxaparin Sodium (generic Lovenox) injection after a single syringe containing a 150 mg/1.0 mL dose was found packaged in a blister pack incorrectly labeled as the 120 mg/0.8 mL strength. This voluntary recall affects 10-count cartons distributed nationwide under the Winthrop US brand. Consumers should verify their medication strength immediately as using the incorrect dose can lead to serious health complications.
A labeling error that causes a patient to receive a higher dose of blood thinner than prescribed (150 mg instead of 120 mg) increases the risk of major bleeding events, which can be life-threatening. No specific injuries were reported in the provided data, but the discrepancy between the syringe label and the outer packaging poses a significant safety risk.
Return to pharmacy for refund and consult healthcare provider.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.